Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prevalence and sequence variations of the genes encoding the five antigens included in the novel 5CVMB vaccine covering group B meningococcal disease.

Vaccine - 4 Mar 2009

Jacobsson Susanne, Hedberg Sara Thulin, Mölling Paula, Unemo Magnus, Comanducci Maurizio, Rappuoli Rino, Olcén Per

Abstract excerpt

During the recent years, projects are in progress for designing broad-range non-capsular-based meningococcal vaccines, covering also serogroup B isolates. We have examined three genes encoding antigens (NadA, GNA1030 and GNA2091) included in a novel vaccine, i.e. the 5 Component Vaccine against Meningococcus B (5CVMB), in terms of gene prevalence and sequence variations. These data were combined with the results...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, Bacterial
Share to Conserved Sequence

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA, Bacterial

Share to Genes, Bacterial

Share to Meningitis, Meningococcal

Share to Meningococcal Infections

Share to Meningococcal Vaccines

Share to Neisseria meningitidis, Serogroup B

Source

Identifiers

PMID: 19162117
DOI: 10.1016/j.vaccine.2008.12.052

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prevalence and sequence variations of the genes encoding the five antigens included in the novel 5CVMB vaccine covering group B meningococcal disease.PMID 19162117Read ↗

Distribution and genetic variability of three vaccine components in a panel of strains representative of the diversity of serogroup B meningococcus.Semantic proximity Read ↗

Sequence constancies and variations in genes encoding three new meningococcal vaccine candidate antigens.Semantic proximity Read ↗

Novel meningococcal 4CMenB vaccine antigens - prevalence and polymorphisms of the encoding genes in Neisseria gonorrhoeae.Semantic proximity Read ↗

Characterization of fHbp, nhba (gna2132), nadA, porA, and sequence type in group B meningococcal case isolates collected in England and Wales during January 2008 and potential coverage of an investigational group B meningococcal vaccine.Semantic proximity Read ↗

Genomic surveillance of Neisseria meningitidis serogroup B invasive strains: Diversity of vaccine antigen types, Brazil, 2016-2018.Semantic proximity Read ↗

Characterization of fHbp, nhba (gna2132), nadA, porA, sequence type (ST), and genomic presence of IS1301 in group B meningococcal ST269 clonal complex isolates from England and Wales.Semantic proximity Read ↗

Neisseria adhesin A variation and revised nomenclature scheme.Semantic proximity Read ↗

Conservation of Meningococcal Antigens in the Genus <i>Neisseria</i>Semantic proximity Read ↗

Meningococcal vaccine antigen diversity in global databases.Semantic proximity Read ↗

Bioinformatics Analysis of Global Diversity in Meningococcal Vaccine Antigens over the Past 10 Years; Vaccine Efficiency PrognosisSemantic proximity Read ↗

Meningococcal B vaccine antigen FHbp variants among disease-causing Neisseria meningitidis B isolates, Italy, 2014-2017.Semantic proximity Read ↗

Diversity of Greek meningococcal serogroup B isolates and estimated coverage of the 4CMenB meningococcal vaccine.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.